Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II/III randomized double-blind trial of HRS-2129 tablets for postoperative abdominal pain
CTR20253766Phase 3Active
- Sponsor
- Shandong Sende
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HRS-2129 in acute pain, postoperative pain, sponsored by Shandong Sende. Started Oct 2025; status: active.
02
Drugs
HRS-2129
03
Conditions
acute painpostoperative pain
Beyond the preview
Go deeper on CTR20253766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253766.